Skip to main content

Table 4 Univariate and multivariate analyses (logistic regression analysis)

From: Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: a single-center retrospective cohort study

Parameters

Crude OR

(95% CI)

p-value

Adjusted OR

(95% CI)

p-value

PIPC/TAZ

9.53 (1.41 – 408)

0.011

9.56 (1.21 – 75.3)

0.032

CKD

6.52 (1.70 – 36.9)

0.0019

5.06 (1.33 – 19.2)

0.017

Diabetes

4.45 (1.35 – 15.8)

0.006

3.16 (1.02 – 9.78)

0.045

  1. OR Odds ratio, CI Confidence interval, PIPC/TAZ Piperacillin/tazobactam, CKD Chronic kidney disease
Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us